Ignorance isn’t bliss when it comes to skin cancer. Here’s what you need to know. By EMILIE DINGFELD
In a pharmaceutical-sponsored clinical trial, researchers at the University of Utah tested a new cancer vaccine made from the herpes simplex virus in patients with advanced melanoma. Sixty-four per cent of tumours injected with it shrank, while 47 per cent disappeared completely. It even helped reduce or eliminate tumours in other parts of the body. By injecting the cancer cells with a virus, it’s thought that the immune system starts to fight these cells as if they were invaders.